CVS:NYE-CVS Health Corp (USD)

COMMON STOCK | Healthcare Plans |

Last Closing

USD 60.34

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.04B

Analyst Target

USD 78.78
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-20 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

N/A

USD 525.99B
ELV Elevance Health Inc

N/A

USD 118.03B
CNC Centene Corp

N/A

USD 32.62B
MOH Molina Healthcare Inc

N/A

USD 16.98B
OSCR Oscar Health Inc

N/A

USD 4.35B
NEUE NeueHealth Inc

N/A

USD 0.05B
CI Cigna Corp

N/A

N/A
HUM Humana Inc

N/A

N/A

ETFs Containing CVS

FHI:CA CI Health Care Giants Cov.. 5.46 % 0.75 %

N/A

CAD 0.08B
WBIY WBI Power Factor® High D.. 5.14 % 0.70 %

N/A

USD 0.06B
FXG First Trust Consumer Stap.. 4.31 % 0.64 %

N/A

USD 0.41B
UNCU:LSE First Trust US Equity Inc.. 2.98 % 0.00 %

N/A

USD 0.04B
ZPRU:XETRA SPDR® MSCI USA Value UCI.. 2.54 % 0.00 %

N/A

USD 0.13B
UVAL:SW SPDR® MSCI USA Value UCI.. 2.54 % 0.00 %

N/A

USD 0.14B
XHS SPDR® S&P Health Care Se.. 2.19 % 0.35 %

N/A

USD 0.08B
VMAX REX VolMAXX Long VIX Futu.. 2.11 % 0.00 %

N/A

USD 6.29M
RSPH Invesco S&P 500® Equal.. 1.82 % 0.00 %

N/A

USD 0.93B
CVY Invesco Zacks Multi-Asset.. 1.09 % 0.65 %

N/A

USD 0.12B
RSPE Invesco Exchange-Traded F.. 0.63 % 0.00 %

N/A

USD 0.02B
FLDZ 0.48 % 0.00 %

N/A

N/A
LUSC:LSE SPDR Barclays 10+ U.S. Co.. 0.43 % 0.00 %

N/A

N/A
LCRP:LSE SPDR Barclays 10+ U.S. Co.. 0.42 % 0.00 %

N/A

USD 0.09B
SUSC:LSE SPDR Barclays 0-3 Year US.. 0.41 % 0.00 %

N/A

N/A
SYBN:F SPDR Barclays 10+ U.S. Co.. 0.37 % 0.00 %

N/A

USD 0.10B
SYBN:XETRA SPDR Barclays 10+ U.S. Co.. 0.37 % 0.00 %

N/A

USD 0.10B
SYBR:F SSgA SPDR ETFs Europe I P.. 0.30 % 0.00 %

N/A

USD 0.23B
SYBR:XETRA SPDR Barclays 3-10 U.S. C.. 0.30 % 0.00 %

N/A

USD 0.23B
IUCB:SW SPDR® Bloomberg 1-10 Yea.. 0.30 % 0.00 %

N/A

USD 0.36B
AGGY WisdomTree Yield Enhanced.. 0.00 % 0.12 %

N/A

USD 0.93B
BSCP Invesco BulletShares 2025.. 0.00 % 0.10 %

N/A

N/A
ESGF 0.00 % 0.40 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

N/A

USD 0.08B
FAB First Trust Multi Cap Val.. 0.00 % 0.70 %

N/A

USD 0.14B
FTA First Trust Large Cap Val.. 0.00 % 0.61 %

N/A

USD 1.22B
IBDL 0.00 % 0.10 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

N/A

N/A
ILTB iShares Core 10+ Year USD.. 0.00 % 0.06 %

N/A

USD 0.62B
LQD iShares iBoxx $ Investmen.. 0.00 % 0.15 %

N/A

N/A
SPLB SPDR Barclays Long Term C.. 0.00 % 0.08 %

N/A

USD 1.03B
IG Principal Exchange-Traded.. 0.00 % 0.26 %

N/A

USD 0.09B
IGLB iShares 10+ Year Investme.. 0.00 % 0.10 %

N/A

USD 2.89B
IBDT iShares iBonds Dec 2028 T.. 0.00 % 0.10 %

N/A

USD 2.28B
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.00 %

N/A

CAD 0.05B
RTH VanEck Retail ETF 0.00 % 0.35 %

N/A

N/A
RWL Invesco S&P 500 Revenue E.. 0.00 % 0.39 %

N/A

N/A
SLQD iShares 0-5 Year Investme.. 0.00 % 0.06 %

N/A

USD 2.10B
SPVU Invesco S&P 500® Enhance.. 0.00 % 0.16 %

N/A

N/A
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

N/A

N/A
ICAN 0.00 % 0.50 %

N/A

N/A
UC84:LSE UBS Barclays US Liquid Co.. 0.00 % 0.00 %

N/A

USD 0.09B
UINC:LSE First Trust US Equity Inc.. 0.00 % 0.00 %

N/A

USD 0.31B
UVAL:LSE SPDR® MSCI USA Value UCI.. 0.00 % 0.00 %

N/A

USD 0.14B
VVAL:LSE 0.00 % 0.00 %

N/A

N/A
USVL:LSE SPDR® MSCI USA Value UCI.. 0.00 % 0.00 %

N/A

USD 0.14B
ZPRU:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

USD 0.13B
VGVL:XETRA 0.00 % 0.00 %

N/A

N/A
GBLO 0.00 % 0.00 %

N/A

N/A
NVQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -61.79% 50% F 6% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -61.79% 50% F 10% F
Trailing 12 Months  
Capital Gain -56.31% 50% F 6% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -56.31% 50% F 10% F
Trailing 5 Years  
Capital Gain -54.67% 50% F 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -54.67% 50% F 17% F
Average Annual (5 Year Horizon)  
Capital Gain 2.71% 38% F 47% F
Dividend Return 5.46% 50% F 48% F
Total Return 2.75% 100% F 57% F
Risk Return Profile  
Volatility (Standard Deviation) 26.98% 25% F 38% F
Risk Adjusted Return 20.25% 38% F 38% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector